A powerful portfolio of SARS-CoV-2 tests Direct virus detection and analysis of immune responses


SARS-CoV-2 assays CE ma EURORealTime SARS-CoV-2


PCR-based detection of SARS-CoV-2 as single parameter or in combination with influenza virus A/B


Anti-SARS-CoV-2 QuantiVac ELISA (IgG) ELISA for quantification of the anti-S1/RBD IgG concentration in standardised units (BAU/ml)


SARS-CoV-2 NeutraLISA Surrogate virus neutralisation test in ELISA format for detection of neutralising antibodies targeting S1/RBD


SARS-CoV-2 IGRA COMING SOON! ELISA-based interferon-gamma release assay (IGRA) for determination of the activity of SARS-CoV-2-reactive T cells via stimulation based on S1/RBD


Comprehensive automation options available!


Visit www.coronavirus-diagnostics.com For further information contact infection-pm@euroimmun.de


EUROIMMUN Medizinische Labordiagnostika AG · Seekamp 31 · 23560 Lübeck (Germany) · Phone: +49 451 20 32-0 · info@euroimmun.de · www.euroimmun.com CE marked


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59